首页 | 本学科首页   官方微博 | 高级检索  
     

利塞膦酸钠对骨质疏松大鼠牙槽骨Bcl-2、BAX表达的影响
引用本文:魏立,周琦,江莉婷,李宁,高益鸣. 利塞膦酸钠对骨质疏松大鼠牙槽骨Bcl-2、BAX表达的影响[J]. 中国口腔颌面外科杂志, 2018, 16(5): 402-408. DOI: 10.19438/j.cjoms.2018.05.004
作者姓名:魏立  周琦  江莉婷  李宁  高益鸣
作者单位:1.上海交通大学医学院附属瑞金医院 口腔科,上海 200025;
2.上海交通大学医学院附属瑞金医院 上海市伤骨科研究所,上海 200025;
3.上海交通大学医学院附属第九人民医院·口腔医学院 口腔修复科, 上海市口腔医学重点实验室,上海 200011;
基金项目:上海市卫生和计划生育委员会科研项目(201640075); 广慈卓越青年培养计划(GCQN-2017-B13)
摘    要:目的: 观察利塞膦酸钠对骨质疏松大鼠下颌牙槽骨显微结构、抗凋亡因子Bcl-2、凋亡因子BAX表达以及骨细胞凋亡的影响。方法: 30只6月龄雌性SD大鼠,随机分为3 组(每组10只),即Sham组(假手术组)、OVX组(接受双侧卵巢切除术)和RIS组(接受双侧卵巢切除术,然后给予利塞膦酸钠);造模3个月后,取各组大鼠下颌骨进行micro-CT扫描,并通过TUNEL染色以及Bcl-2、BAX免疫组织化学染色检测下颌骨骨细胞的凋亡。采用SPSS 13.0软件包对组间数据进行比较。结果: 与Sham组相比,OVX组牙槽骨丧失和骨细胞凋亡明显增多;RIS组与OVX组相比,骨细胞凋亡显著减少,BV/TV显著增加,Bcl-2 表达增加,Bcl-2/BAX比值增加(P<0.05)。结论: 利塞磷酸钠增加下颌牙槽骨中Bcl-2的表达和Bcl-2/BAX的比值,部分逆转去卵巢骨质疏松大鼠的牙槽骨丧失,减少下颌骨骨细胞凋亡。

关 键 词:卵巢切除术  下颌牙槽骨  二膦酸盐  骨质疏松症  骨细胞凋亡  
收稿时间:2018-04-09

Effects of risedronates on Bcl-2 and BAX expression in osteoporotic rat mandibular alveolar bone
WEI Li,ZHOU Qi,JIANG Li-ting,LI Ning,GAO Yi-ming. Effects of risedronates on Bcl-2 and BAX expression in osteoporotic rat mandibular alveolar bone[J]. China Journal of Oral and Maxillofacial Surgery, 2018, 16(5): 402-408. DOI: 10.19438/j.cjoms.2018.05.004
Authors:WEI Li  ZHOU Qi  JIANG Li-ting  LI Ning  GAO Yi-ming
Affiliation:1.Department of Stomatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Shanghai 200025;
2.Shanghai Institute of Traumatology and Orthopaedics. Shanghai 200025;
3.Department of Prosthodontics, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; Shanghai Key Laboratory of Stomatology. Shanghai 200011, China
Abstract:PURPOSE: This study was to investigate the impact of risedronates on mandibular alveolar bone microstructure, anti-apoptotic factor Bcl-2 and apoptotic factor BAX expression and osteocyte apoptosis in an ovariectomized rat model. METHODS: Thirty 6-month-old female SD rats were divided into 3 groups (ten in each group): Sham group, OVX group (bilateral ovariectomy) and RIS group (bilateral ovariectomy, followed by administration of risedronate). Three months later, the mandibles of all animals were harvested and assessed by micro-CT and histological analysis. Osteocyte apoptosis was observed by TUNEL staining and the expression of Bcl-2 and BAX was evaluated by immunohistochemical staining. The data were analyzed using SPSS 13.0 software package. RESULTS: Ovariectomy caused significant alveolar bone loss and greater osteocyte apoptosis in OVX group than in sham group. The systemic risedronate-treated group exhibited a significant increase in BV/TV and decrease in trabecular separation and osteocyte apoptosis, together with an increase in Bcl-2 expression and the ratio of Bcl-2/BAX, when compared with those of the OVX group (P<0.05). CONCLUSIONS: Systemic treatment of risedronates can increase the expression of Bcl-2 and the ratio of Bcl-2/BAX in mandibular alveolar bone. It partially reverses alveolar bone loss and suppresses osteocyte apoptosis in ovariectomized rats.
Keywords:Ovariectomy  Mandibular alveolar bone  Bisphosphonates  Osteoporosis  Osteocyte apoptosis  
点击此处可从《中国口腔颌面外科杂志》浏览原始摘要信息
点击此处可从《中国口腔颌面外科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号